| scholarly article | Q13442814 |
| P50 | author | Michal Abrahamowicz | Q42305888 |
| P2093 | author name string | John M Esdaile | |
| Hyon K Choi | |||
| J Antonio Aviña-Zubieta | |||
| Diane Lacaille | |||
| Marie-Pierre Sylvestre | |||
| M Mushfiqur Rahman | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cerebrovascular disease | Q3010352 | ||
| P304 | page(s) | 990-995 | |
| P577 | publication date | 2011-03-02 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study | |
| P478 | volume | 70 |
| Q36411744 | Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) f |
| Q40212689 | High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. |
| Q58160099 | Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study |
| Q39057277 | Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. |
| Q41507453 | Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study. |
| Q98467249 | Interstitial lung disease in dermatomyositis complicated by right ventricular thrombus secondary to macrophage activation syndrome- a case report |
| Q37704498 | Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q36327186 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? |
| Q35957651 | Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England |
| Q40513822 | Risk of Myocardial Infarction and Stroke in Patients With Granulomatosis With Polyangiitis (Wegener's): A Population-Based Study |
| Q33588440 | Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study |
| Q33926524 | Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study |
| Q40479785 | Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. |
| Q38797087 | Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. |
| Q38744550 | The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study |
| Q35135831 | The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. |
| Q39121484 | The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study |
| Q33822203 | The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study |
Search more.